Shop
-1.png)
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 29 2025
JAMA Dermatology has recently published the results of a retrospective cohort study evaluating the efficacy of supplementation with nicotinamide, vita...
Two controlled trials evaluating supplemental myo-inositol have recently been published. The first, in the journal Diabetes, Obesity & Metabolism, was a randomized and placebo-controlled trial evaluating the effect of a combination of myo-inositol and zinc on insulin resistance (HOMA-IR) among children with obesity. Fifty children completed this three-month study, which took place in Italy. Participants received either a placebo containing 1g galactooligosaccharides (GOS) or a combination including 2g myo-inositol (MI), 5mg zinc gluconate, as well as 1g GOS, and all participants followed a Mediterranean-style isocaloric diet. While there was no overall benefit in the experimental group, children with severe obesity had significantly lower fasting insulin and HOMA-IR in the myo-inositol group compared to placebo.
The second was a randomized and controlled trial comparing the use of metformin to the combination of MI and D-chiro-inositol (DCI) in a 40:1 ratio, a formula previously shown to improve hormonal and metabolic parameters among women with polycystic ovarian syndrome (PCOS). This recent trial equally divided 60 women with PCOS to receive either MI and DCI or metformin for 12 weeks. Both groups had significant and similar improvements in multiple parameters, including insulin sensitivity, menstrual regularity, BMI, quality of life, SHBG, etc. Metformin had a slightly better effect on insulin sensitivity, but this may have been from an overrepresentation of the type A phenotype of PCOS in that group. There was also a suggestion that MI and DCI may be more effective for the C and D phenotypes (ovulatory and non-hyperandrogenic PCOS), which would need to be confirmed in larger trials. The evidence for MI and DCI as a safe and effective alternative for PCOS and insulin resistance continues to grow.
Submit this form and you'll receive our latest news and updates.
“Clinical guidelines have progressively lowered the recommended LDL-C target for high-risk CVD patients to below 70 mg/d...
Learn moreA recent study has concluded that the LDL cholesterol of a specific group of people given a carbohydrate-restricted diet...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
Proposition 65 Warning
© 2025 Biotics Research Corporation - All Rights Reserved
Submit your comment